Evidence map›Paper›PMID 41612346›Full record

ArticleFluids and barriers of the CNS2026

Modeling glioma-induced impairments on the glymphatic system.

Alexandre Poulain, Jørgen Riseth, Kyrre E Emblem, Kent-Andre Mardal

Abstract read
PubMed Publisher
In one paragraph

Article in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandre Poulain *Université de Lille, CNRS, UMR 8524 Laboratoire Paul Painlevé, Lille, F-59000, France.
Jørgen Riseth *Department of Mathematics, University of Oslo, Oslo, Norway.
Kyrre E Emblem *Department of Physics and Computational Radiology, Clinic for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Kent-Andre Mardal *Department of Mathematics, University of Oslo, Oslo, Norway. kent-and@simula.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Altered glymphatic function is observed for many neurological diseases. Glioma, one of the most common brain cancers, is known to have altered fluid dynamics in terms of edema and blood-brain barrier breakdown, both features potentially impacting the glymphatic function. To study glioma and its fluid dynamics, we propose a flexible mathematical model, including the tumor, the peri-tumoral edema and the healthy tissue. From a mechanical point of view, we consider the brain as a multicompartment porous medium and model both the fluid movement and the clearance of solutes within the brain. Our results indicate that the impairment of the glymphatic system due to glioma growth is two-fold. First, edema resulting from the leakage of fluid at the blood-brain barrier and/or the occlusion of the interstitial fluid exit routes (notably the perivascular spaces) due to migratory tumor cells result in a slight localized increase of pressure, consequently impairing negatively glymphatic clearance. Second, local changes of porosity (i.e. the volume fraction of certain compartments such as perivascular or extracellular spaces), result in a disruption of the transport of solutes in the brain. Our results indicate that an effect similar to the enhanced permeability and retention is obtained using biologically relevant changes of parameter values of our model. Our mathematical model is the first step towards a digital twin for drug or contrast product delivery within the cerebro-spinal fluid directly (e.g. from intrathecal injection) for patients suffering from gliomas.

Indexed as

Brain NeoplasmsGliomaGlymphatic SystemModels, BiologicalAnimalsBlood-Brain BarrierBrain EdemaHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.